AJP
Log in and stay connected
From 1 November 2021 AJP.com.au will be accessible only to pharmacists and other healthcare professionals. Find out how to log in and stay in This move will ensure the continued …
Gerald Tracey: Collaborative care and supporting the transition to biosimilars
Rheumatologist, Dr Gerald Tracey explains the opportunities biosimilars present for prescribing physicians, particularly given the government supported streamlined process. Gerald highlights the advantages of collaborative care between the prescriber and …
Trent Twomey: The role of pharmacists and physicians in supporting a patient-centric narrative
Trent Twomey, the National President of the Pharmacy Guild of Australia highlights the shifting power dynamic from physicians to patients in determining what medicines they are prescribed. Collaborative care is …
Andrew Oster: The power of collaborative care in transitioning to biosimilars
Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises …
Eric Chan: Cultivating a relationship of trust between pharmacist and physician
Head of Pharmacy at Blooms The Chemist, Eric Chan emphasises the importance of collaborative care in cultivating a relationship of trust and transparency between a pharmacist and physician. He outlines …
George Tambassis: Empowering and educating pharmacists on biosimilars
George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy …
Professor Andrew McLachlan presents the recent trends and gaps identified in OA pain management
In this video, Professor Andrew McLachlan discusses how a patient’s health literacy can impact their choice of self-management strategies for OA symptoms and how a lack of condition awareness can …
Professor Andrew McLachlan explains how pharmacists play a critical role in identifying and supporting patients with Osteoarthritis
A recent study found only 3.5% of participants with self-reported OA symptoms sought advice from a pharmacist despite the critical role pharmacists play in helping patients on their pain management …
APP2021: Annalee Combis talks about the latest trends in the VMS category
Over the past year, Australians are increasingly seeking for more holistic solutions for their wellness needs. In this interview, Annalee Combis, Marketing Lead – Wellness at GSK Consumer Healthcare talks to Miranda Deakin on the latest buyer trends in the VMS …
APP2021: James Meins talks about the growth opportunity in the pain category
The 2021 Panadol Care Study found Australians are feeling more physical pain than before, particularly among the younger generations. James Meins, Senior Marketing Manager at GSK Consumer Healthcare joined Miranda Deakin on stage at …
Pathophysiology and early intervention of common colds
Did you know that 90% of common colds are caused by viruses? Watch renowned pharmacist, John Bell debunk the myth of anti-bacterials in common cold management, shedding light to its …
Early intervention for common cold and how to stop it at the first signs
Leading Pharmacist John Bell discussed the time-course of the common cold and the evidence of early intervention to stop common colds. He also unveiled the dual advantage technology behind the …